Rentschler Biotechnologie GmbH & Co. Commissions New 500 Liter GMP Manufacturing Suites

Published: Jul 23, 2007

Laupheim, July 23, 2007 -- With the commissioning of two new GMP manufacturing suites, Rentschler Biotechnologie looks forward to completing the first phase expansion of its operations. Both systems will be used to produce therapeutic proteins and monoclonal antibodies.

Back to news